These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture. Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938 [TBL] [Abstract][Full Text] [Related]
8. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase. Covey DF; Hood WF Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors. Lovett JA; Darby MV; Counsell RE J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo. Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466 [TBL] [Abstract][Full Text] [Related]
12. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues. Marcotte PA; Robinson CH Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221 [TBL] [Abstract][Full Text] [Related]
13. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione. Covey DF; Hood WF Mol Pharmacol; 1982 Jan; 21(1):173-80. PubMed ID: 7132956 [No Abstract] [Full Text] [Related]
14. Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors. Rowlands MG; Foster AB; Mann J; Pietrzak B; Wilkinson J; Coombes RC Steroids; 1987; 49(4-5):371-82. PubMed ID: 3455049 [TBL] [Abstract][Full Text] [Related]
15. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione. Abul-Hajj YJ; Liu XP; Hedge M Steroids; 1995 May; 60(5):423-7. PubMed ID: 7570717 [TBL] [Abstract][Full Text] [Related]
16. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962). Johnston JO; Wright CL; Holbert GW; Benson HD J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520 [TBL] [Abstract][Full Text] [Related]
17. 6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships. Numazawa M; Yamaguchi S J Steroid Biochem Mol Biol; 1998 Oct; 67(1):41-8. PubMed ID: 9780028 [TBL] [Abstract][Full Text] [Related]
18. 7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis. Darby MV; Lovett JA; Brueggemeier RW; Groziak MP; Counsell RE J Med Chem; 1985 Jun; 28(6):803-7. PubMed ID: 4009603 [TBL] [Abstract][Full Text] [Related]
19. Thiol-containing androgens as suicide substrates of aromatase. Bednarski PJ; Porubek DJ; Nelson SD J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599 [TBL] [Abstract][Full Text] [Related]